Risk of tuberculosis after initiation of antiretroviral therapy among persons with HIV in Europe

•The tuberculosis (TB) risk after antiretroviral treatment (ART) initiation in Europe is studied.•TB peaked within 3 months post ART (14.41/1000 PY).•TB was linked to certain baseline risk factors.•TB risk declined over time but remained above European background.•Thorough TB risk assessment essenti...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	International journal of infectious diseases Ročník 147; s. 107199
Hlavní autoři:	Johansen, Isik S., Roen, Ashley, Kraef, Christian, Martín-Iguacel, Raquel, Nemeth, Johannes, Fenner, Lukas, Zangerle, Robert, Llibre, Josep M., Miller, Robert F., Suarez, Isabelle, de Wit, Stephane, Wit, Ferdinand, Mussini, Christina, Saracino, Annalisa, Canetti, Diana, Volny-Anne, Alain, Jaschinski, Nadine, Neesgaard, Bastian, Ryom, Lene, Peters, Lars, Garges, Harmony P., Rooney, James F., Podlekareva, Daria, Mocroft, Amanda, Kirk, Ole
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Canada Elsevier Ltd 01.10.2024 Elsevier
Témata:	Adult AIDS Anti-HIV Agents - adverse effects Anti-HIV Agents - therapeutic use CD4 Lymphocyte Count Cohort Studies Europe - epidemiology Female HIV Infections - drug therapy HIV Infections - epidemiology Humans Incidence Male Middle Aged Risk Factors TB/HIV Tuberculosis - epidemiology Europe AIDS ART TB/HIV incidence
ISSN:	1201-9712, 1878-3511, 1878-3511
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!